Definium Therapeutics, Inc. (DFTX) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Definium Therapeutics, Inc. (DFTX) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

DFTX Income Statement

Definium Therapeutics, Inc. (DFTX) annual income statement — 11-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	0	0	0	0	0	0	0	0	527K	0	0	0	0	0	0	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	-527K	0	0	0	0	0	0	0	0	0	0
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-	-	-	-	-	100%	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	75.08M	59.22M	47.58M	45.67M	40.9M	32.16M	32.46M	24.79M	24.46M	21.68M	22.2M	21.62M	29.18M	20.86M	13.9M	16.98M	16.94M	18.5M	17.56M	17.23M
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	26.41M	17.74M	14.06M	14.69M	11.09M	8.8M	10.7M	7.6M	9.81M	10.5M	10.66M	8.41M	14.41M	8.26M	5.07M	9.21M	7.62M	8.26M	6.67M	8.21M
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research & Development	48.66M	41.48M	33.52M	30.98M	29.81M	23.36M	21.76M	17.19M	14.64M	11.18M	11.55M	13.2M	14.78M	12.6M	8.83M	7.77M	9.33M	10.24M	10.88M	9.02M
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	-75.08M	-59.22M	-47.58M	-45.67M	-40.9M	-32.16M	-32.46M	-24.79M	-24.46M	-22.2M	-22.2M	-21.62M	-29.18M	-20.86M	-13.9M	-16.98M	-16.94M	-18.5M	-17.56M	-17.23M
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-83.55%	-84.15%	-46.57%	-84.21%	-67.24%	-44.83%	-	-	-	-	-59.75%	-27.28%	-72.25%	-12.74%	20.83%	1.42%	62.53%	-33.63%	46.84%	-130.18%
EBITDA	-157.75M	-58.59M	-40.74M	-45.66M	-40.41M	-22.75M	-31.74M	-12.96M	-5.39M	-21.68M	-21.41M	-20.82M	-28.39M	-20.07M	-13.11M	-16.19M	-16.12M	-17.73M	-17.55M	-16.44M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	-290.42%	-157.58%	-28.37%	-252.41%	-649.93%	-4.93%	-	-	-	-	-63.35%	-28.61%	-76.11%	-13.24%	25.32%	1.49%	63.72%	-39.91%	46.63%	-123.77%
D&A (Non-Cash Add-back)	0	631K	0	6.75K	0	0	725K	11.84M	0	527K	790K	791K	790K	791K	790K	790K	820K	780K	4K	789K
EBIT	-157.75M	-75.85M	-40.74M	-65.99M	-40.41M	-22.75M	-34.09M	-12.96M	-5.39M	-53.97M	-22.2M	-17.59M	-29.05M	-24.74M	-13.9M	-16.98M	-16.94M	-18.5M	-17.56M	-17.23M
Net Interest Income	2.35M	2.21M	-6.21M	988K	436K	1.83M	2.62M	2.78M	2.65M	1.22M	905K	1.16M	1.31M	1.28M	1.05M	360K	82K	-27K	-386K	-64K
Interest Income	3.59M	3.46M	3.49M	2.26M	2.77M	2.43M	3.28M	3.51M	3.12M	1.66M	905K	1.16M	1.39M	1.36M	1.05M	360K	82K	0	-27K	0
Interest Expense	1.23M	1.25M	9.7M	1.27M	2.34M	602K	656K	727K	466K	434K	0	0	77K	76K	0	0	-	27K	359K	64K
Other Income/Expense	-83.91M	-17.88M	-2.86M	-21.6M	-1.84M	8.81M	-2.28M	11.11M	18.6M	-32.2M	-1.66M	3.69M	54K	-3.95M	9M	498K	-14K	54K	-428K	31K
Pretax Income	-158.99M	-77.1M	-50.44M	-67.27M	-42.74M	-23.35M	-34.74M	-13.68M	-5.85M	-54.4M	-23.86M	-17.92M	-29.13M	-24.82M	-4.9M	-16.48M	-16.96M	-18.45M	-17.99M	-17.2M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-1.16M	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	6.43%	0%
Net Income	-158.99M	-77.1M	-50.44M	-67.27M	-42.74M	-23.35M	-34.74M	-13.68M	-5.85M	-54.4M	-23.86M	-17.92M	-29.13M	-24.82M	-4.9M	-16.48M	-16.96M	-18.45M	-16.83M	-17.2M
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-271.95%	-230.21%	-45.18%	-391.56%	-630.17%	57.08%	-	-	-	-	-386.72%	-8.72%	-71.79%	-34.49%	70.87%	4.13%	62.53%	-34.1%	-34.5%	-98.22%
Net Income (Continuing)	-158.99M	-77.1M	-50.44M	-67.27M	-42.74M	-23.35M	-34.74M	-13.68M	-5.85M	-54.4M	-23.86M	-17.92M	-29.13M	-24.82M	-4.9M	-16.48M	-16.96M	-18.45M	-16.83M	-17.2M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-1.44	-0.71	-0.50	-0.78	-0.50	-0.35	-0.41	-0.17	-0.08	-1.14	-0.59	-0.45	-0.76	-0.65	0.11	-0.55	-0.60	-0.66	-3.32	-0.83
EPS Growth %	-188%	-102.86%	-21.95%	-358.82%	-514.25%	69.3%	-	-	-	-	-636.36%	18.18%	-26.67%	1.52%	103.31%	33.73%	54.89%	-15.79%	-591.67%	-80.43%
EPS (Basic)	-1.44	-0.71	-0.51	-0.78	-0.50	-0.27	-0.41	-0.18	-0.08	-1.14	-0.59	-0.45	-0.76	-0.65	0.11	-0.55	-0.60	-0.66	-3.32	-0.83
Diluted Shares Outstanding	110.68M	108.79M	89.33M	85.89M	85.35M	87.09M	83.93M	80.24M	71.91M	47.86M	40.28M	39.72M	38.58M	38.08M	37.98M	29.3M	28.24M	28.15M	28.05M	28.01M
Basic Shares Outstanding	110.68M	108.79M	89.33M	85.89M	85.35M	85.07M	83.93M	77.91M	71.91M	47.86M	40.28M	39.72M	38.58M	38.08M	37.98M	29.3M	28.24M	28.15M	28.05M	28M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-